Posters

Postoperative clinically significant macular oedema

Poster Details

First Author: H. Arzoallxhiu KOSOVO

Co Author(s):    I. Jurik   N. Polloshka-Arzoallxhiu   L. Hoxha   H. Gashi   A. Kastrati        

Abstract Details

Purpose:

To report the incodence of clinical macular oedema (CMO) and its risk factors following cataract surgery

Setting:

Ophthalmology Department of Prizren Regional Hospital and American Vision Eye Center in Prizren Kosovo

Methods:

Data for the study was obtained from the Ophthalmology Department of Prizren Regional Hospital and American Vision Eye Center in Prizren Kosovo. Description and regression analyses were performed.

Results:

Between January 2012 and January 2016, we have recorder 7956 cataract surgeries. Incidence of CMO was 1 % (79 cases).Diabetes mellitus existed in 40.2% of these patient compared to 30.6% in those without CMO. Significant ocular comorbidity risk factors for CMO are chronic uveitis, non-proliferative diabetic retinopa and clinically significant diabetic macular oedema (CSMO) . Risk of CMO is higher in phacoemulsification converted to extracapsular cataract extraction (ECCE) odds ration 4.34, p less than 0.001) and ECCE (odds ratio 2.74, p less than 0.001) compared to pkhacoemulsification (odds ratio 1.06, p= 0.58). Intraoperative complications associated with higher risk of CMo include posterior capsular rupture with or without loss of vitreous and zonular dialysis with vitreous loss

Conclusions:

Clinically significant CMO is an uncommon but important postoperative complication. The raste documented in this analyses is comparable to those reported elsewere. Risk factors associated with CMO are chronic uveitis, NPDR,CSMO, phacoemulsification convetred to ECCE, ECCE, posterior capsular rupture with or without vitreous loss and zonular dialysis with vitreous loss.

Financial Disclosure:

NONE